John Libbey Eurotext

European Journal of Dermatology

MENU

Acrodermatitis continua of Hallopeau with insufficient response to ixekizumab and infliximab, successfully treated with a combination of ustekinumab and tofacitinib Volume 33, issue 2, March-April 2023

Figures


  • Figure 1
Authors
1 Department of Dermatology, The University of Hong Kong Shenz hen Hospital, Shenzhen, China 518053
2 Department of Rheumatology, The University of Hong Kong Shenzhen Hospital, Shenzhen, China 518053

Acrodermatitis continua of Hallopeau (ACH) is a rare subtype of pustular psoriasis that presents as a sterile, pustular eruption, and commonly involves the digits. It affects both the skin and nail bed, and causes onychodystrophy, anonychia, and joint involvement [1]. Due to the low incidence, there is no standardized guidelines for treatment of ACH. In recent years, monoclonal antibodies are used as alternatives when ACH is resistant to conventional therapies, such as acitretin, methotrexate or [...]

Licence This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License